Emostasi e Trombosi, Società Italiana di. “OC10 | FROM DESIGN TO CLINICAL PHASE 3 IN ONCOLOGY: CD13-TARGETED TISSUE FACTOR AND TUMOR INFARCTION: W.E. Berdel, C. Schwöppe, C. Brand, K. Hessling, A.F. Berdel, T. Kessler, G. Lenz, R.M. Mesters, C. Schliemann | Department of Medicine A, University Hospital, Muenster, Germany”. Bleeding, Thrombosis and Vascular Biology 5, no. s1 (April 16, 2026). Accessed April 17, 2026. https://www.btvb.org/btvb/article/view/493.